Faisal Mehmud - Dec 31, 2024 Form 3/A - Amendment Insider Report for Medicus Pharma Ltd. (MDCX)

Role
Chief Medical Officer
Signature
/s/ James Quinlan, as Attorney-in-Fact, for Faisal Mehmud
Stock symbol
MDCX
Transactions as of
Dec 31, 2024
Transactions value $
$0
Form type
3/A - Amendment
Date filed
4/3/2025, 06:52 PM
Date Of Original Report
Dec 31, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MDCX Stock Option (right to buy) Dec 31, 2024 Common Shares 100K $2.26 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the vesting schedule of the Reporting Person's options. The options vest annually in five equal installments beginning on November 14, 2025.
F2 Represents an exercise price of $3.25 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.